Category Industry Updates

Kanbrick Partners with McVaugh and Hiller Families to Acquire Laboratory Testing Inc.

Kanbrick Partners with Laboratory Testing Inc. to Fuel Long-Term Growth in Materials Testing and Calibration In a strategic move aimed at accelerating growth and innovation within the critical field of materials testing and calibration, Kanbrick—a long-term investment partnership committed to…

Read MoreKanbrick Partners with McVaugh and Hiller Families to Acquire Laboratory Testing Inc.

TOKU-E Launches High-Purity Pirlimycin Hydrochloride for Enhanced Food Safety Testing

​TOKU-E Company, a global manufacturer specializing in small molecules, gene selectors, and fine chemicals for upstream manufacturing, has announced the availability of high-purity for food safety testing. This development aims to enhance the reliability of diagnostic kits used to detect…

Read MoreTOKU-E Launches High-Purity Pirlimycin Hydrochloride for Enhanced Food Safety Testing

BASF’s Chemically Recycled Ultramid® Supports TE’s Sustainability Goals

BASF’s Chemically Recycled Ultramid® Supports TE’s Sustainability Goals Chemically At CHINAPLAS 2025, TE Connectivity (TE) and BASF will jointly introduce a new TE automotive connector with components made from BASF Ultramid® Ccycled® polyamide, a circular solution with an attributed share…

Read MoreBASF’s Chemically Recycled Ultramid® Supports TE’s Sustainability Goals

LabTAG & eLabNext Unveil DYMO® LabelWriter™ 5-Series Add-On for Effortless Lab Labeling

GA International Expands Laboratory Labeling Solutions with eLabNext Integration for Dymo® LabelWriter™ 5-Series LabTAG GA International, a global leader in laboratory identification solutions under its LabTAG brand, has LabTAG announced an exciting new advancement in laboratory labeling technology. The company…

Read MoreLabTAG & eLabNext Unveil DYMO® LabelWriter™ 5-Series Add-On for Effortless Lab Labeling

Wacker Biotech Partners with RNAV8 Bio to Advance mRNA Therapeutics Innovation

Wacker Biotech, a globally recognized contract development and manufacturing organization (CDMO) and a wholly owned subsidiary of Wacker Chemie AG, has officially entered into a strategic collaboration with RNAV8 Bio, a Boston-based biotechnology company specializing in mRNA engineering. This partnership…

Read MoreWacker Biotech Partners with RNAV8 Bio to Advance mRNA Therapeutics Innovation